Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) shot up 4.9% on Friday after Bank of America raised their price target on the stock from $24.00 to $26.00. Bank of America currently has a buy rating on the stock. Stevanato Group traded as high as €24.90 ($26.21) and last traded at €23.57 ($24.81). 371,527 shares were traded during mid-day trading, a decline of 26% from the average session volume of 499,755 shares. The stock had previously closed at €22.47 ($23.65).
A number of other equities analysts also recently issued reports on STVN. Morgan Stanley reissued an “equal weight” rating and issued a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Wolfe Research assumed coverage on Stevanato Group in a report on Friday. They issued an “outperform” rating and a $28.00 target price on the stock. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of €28.60 ($30.11).
View Our Latest Stock Report on Stevanato Group
Institutional Investors Weigh In On Stevanato Group
Stevanato Group Trading Up 5.0 %
The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The firm has a fifty day moving average price of €19.58 and a two-hundred day moving average price of €19.65.
Stevanato Group (NYSE:STVN – Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. During the same period last year, the firm earned $0.16 earnings per share. Stevanato Group’s quarterly revenue was up 2.4% on a year-over-year basis. On average, equities research analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Recommended Stories
- Five stocks we like better than Stevanato Group
- How to Calculate Options Profits
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 3 Warren Buffett Stocks to Buy Now
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Consumer Discretionary Stocks Ready for a Comeback in 2025
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.